---
document_datetime: 2023-09-21 20:25:50
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/kesimpta-epar-all-authorised-presentations_en.pdf
document_name: kesimpta-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9062252
conversion_datetime: 2025-12-25 01:47:37.548013
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form    | Route of administration   | Immediate packaging               | Content (concentration)   | Pack size                                 |
|------------------|-------------------|------------|------------------------|---------------------------|-----------------------------------|---------------------------|-------------------------------------------|
| EU/1/21/1532/001 | Kesimpta          | 20 mg      | Solution for injection | Subcutaneous use          | pre-filled syringe (glass)        | 0.4 ml (50 mg/ml)         | 1 pre-filled syringe                      |
| EU/1/21/1532/002 | Kesimpta          | 20 mg      | Solution for injection | Subcutaneous use          | pre-filled syringe (glass)        | 0.4 ml (50 mg/ml)         | 3 (3 x 1) pre-filled syringes (multipack) |
| EU/1/21/1532/003 | Kesimpta          | 20 mg      | Solution for injection | Subcutaneous use          | syringe (glass) in pre-filled pen | 0.4 ml (50 mg/ml)         | 1 pre-filled pen                          |
| EU/1/21/1532/004 | Kesimpta          | 20 mg      | Solution for injection | Subcutaneous use          | syringe (glass) in pre-filled pen | 0.4 ml (50 mg/ml)         | 3 (3 x 1) pre-filled pens (multipack)     |